Enhanced Anti-Brain Metastasis from Non-Small Cell Lung Cancer of Osimertinib and Doxorubicin Co-Delivery Targeted Nanocarrier

PURPOSE: Currently, the treatment of brain metastases from non-small cell lung cancer (NSCLC) is rather difficult in the clinic. A combination of small molecule-targeted drug and chemo-drug is a promising therapeutic strategy for the treatment of NSCLC brain metastases. But the efficacy of this comb...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoqi, Mao, Wenxing, Wang, Zhi, Li, Xinrui, Xiong, Yaokun, Lu, Hongjin, Wang, Xiuzhen, Yin, Haoyuan, Cao, Xiang, Xin, Hongliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425109/
https://www.ncbi.nlm.nih.gov/pubmed/32848385
http://dx.doi.org/10.2147/IJN.S258699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425109/
https://www.ncbi.nlm.nih.gov/pubmed/32848385
http://dx.doi.org/10.2147/IJN.S258699

Ejemplares similares